Your shopping cart is currently empty

MAGL-IN-13 (compound(3R,4S)-5v) is a selective, irreversible MAGL inhibitor with IC50 values of 0.026 nM for mMAGL, 0.021 nM for hMAGL, and 0.24 nM for rMAGL. Additionally, MAGL-IN-13 is capable of crossing the blood-brain barrier.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | MAGL-IN-13 (compound(3R,4S)-5v) is a selective, irreversible MAGL inhibitor with IC50 values of 0.026 nM for mMAGL, 0.021 nM for hMAGL, and 0.24 nM for rMAGL. Additionally, MAGL-IN-13 is capable of crossing the blood-brain barrier. |
| In vitro | MAGL-IN-13, when pre-incubated at 37℃ for 10 minutes, inhibits mMAGL, hMAGL, and rMAGL with IC50 values of 0.026, 0.021, and 0.24 nM, respectively. It irreversibly inhibits MAGL activity. MAGL-IN-13, at 0.1 and 1 μM, exhibits selectivity for MAGL. In NIH3T3 mouse fibroblasts, it shows low cytotoxicity with a cell viability IC50 of 0.47 μM. At a concentration of 10 μM, it can inhibit Ca2+ channels in rats. |
| In vivo | Administered intraperitoneally at a dose of 5 mg/kg, MAGL-IN-13 effectively suppresses brain MAGL activity in a dose-dependent manner. Animal Model: Adult male mice with MAGL inhibition. |
| Formula | C28H24FN5O4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.